Experience with dipipanone elixir in the management of cancer related pain--case study.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 7514073.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The synthetic opioid dipipanone is infrequently used in the UK in the management of malignant pain, principally because of the inflexibility of the Diconal combination preparation (dipipanone 10 mg with cyclizine 30 mg). We present three patients in which dipipanone elixir proved to be their own drug of choice in the management of opioid responsive cancer pain, and our experience with 15 other patients. Dipipanone elixir was formulated 10 mg/5 ml, in single strength chloroform water.
Medical subject headings
- Analgesics
- Methadone
- Neoplasms
- Intractable Pain
- Palliative Care